MoneyWorks4Me

Aurobindo Pharma informs about disclosure

02 May 2024 Evaluate

With reference to its letter dated February 5, 2024, informing about disposal of business assets of Eugia US Manufacturing LLC, a wholly owned step- down subsidiary of the Company. In this regard, Aurobindo Pharma has informed that the aforementioned disposal of business assets has been completed on May 1, 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1746.75
Dr. Reddys Labs. 1179.00
Cipla 1296.70
Lupin 1945.95
Zydus Lifesciences 1116.10
View more..